E I D Parry India (EIDPARRY) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
11 Nov, 2025Executive summary
Global sugar market expected to remain in surplus through 2025-2026, with Brazil, India, and Thailand increasing supply; Indian output projected to rise 15% for sugar year 2026, aided by favorable monsoon.
Consolidated Q2 FY26 revenue rose 24% YoY to ₹11,624 Cr; H1 revenue up 27% YoY to ₹20,348 Cr; FY25 revenue at ₹7,523 Cr.
EBITDA for Q2 grew 31% YoY to ₹1,349 Cr; H1 EBITDA up 44% YoY to ₹2,244 Cr; FY25 EBITDA at ₹257 Cr.
PAT after NCI for Q2 was ₹424 Cr, up from ₹306 Cr YoY; H1 PAT was ₹671 Cr, up from ₹397 Cr YoY.
Strategic focus on cane volume, distillery agility, institutional business expansion, and consumer product growth.
Financial highlights
Sugar segment Q2 revenue was ₹368 Cr (flat YoY); H1 FY26 sales were 1.73 LMT at ₹42.14/kg, with improved realizations but lower volumes.
Distillery H1 FY26 volume grew 5% YoY, with better average realization at ₹67.62/litre; Q2 revenue ₹291 Cr (+4% YoY).
Refinery H1 FY26 sales: 4.57 LMT, revenue $240.25 Mn, EBITDA $9.58 Mn, PBT after exceptionals $3.71 Mn.
Nutraceuticals H1 FY26 revenue at ₹88 Cr, PBIT ₹13 Cr, including a one-time insurance claim of ₹18 Cr.
Standalone Q2 loss after tax was ₹285 Cr, mainly due to a ₹352 Cr impairment provision.
Outlook and guidance
Ethanol blending in petrol reached 19.17% as of Sep 2025, targeting 20% for ESY 2025-26.
Strategic initiatives to reduce bulk sugar sales and focus on value-added and premium products.
Consumer business expected to return to growth in Q3 and Q4 as quotas increase and staple prices stabilize.
No immediate plans for capacity addition in distilleries due to industry overcapacity and policy uncertainty.
Company is transforming from a sugar enterprise to a comprehensive food, nutrition, and bioenergy business.
Latest events from E I D Parry India
- Q3 FY26 revenue up 18% YoY; profit at Rs. 232 Cr; volumes down, realizations and distillery up.EIDPARRY
Q3 25/2613 Feb 2026 - Q3 FY25 revenue up 12% YoY to ₹8,720 crore; EBITDA up 79%; strong CPG and distillery growth.EIDPARRY
Q3 24/2516 Dec 2025 - Improved realizations and distillery gains offset lower volumes; revenue and profit increased.EIDPARRY
Q1 25/2623 Nov 2025 - Consolidated revenue rose to Rs. 31,609 crore, but net loss followed major impairment.EIDPARRY
Q4 24/2521 Nov 2025 - Revenue up, profits down; distillery and retail strong, borrowings rise, nutraceuticals weak.EIDPARRY
Q2 24/2527 Aug 2025 - Revenue and profit declined year-over-year, but Consumer Products and Distillery segments grew strongly.EIDPARRY
Q1 24/2527 Aug 2025